CA Stock MarketDetailed Quotes

XRTX XORTX Therapeutics Inc

Watchlist
  • 1.640
  • -0.060-3.53%
15min DelayTrading Dec 12 13:35 ET
5.29MMarket Cap10.12P/E (TTM)

XORTX Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
29.78%-751.85K
57.41%-736.54K
47.54%-1.3M
26.56%-6.58M
64.08%-1.3M
-10.66%-1.07M
7.95%-1.73M
0.74%-2.49M
-86.70%-8.96M
-14.81%-3.61M
Net income from continuing operations
55.98%-587.01K
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
Operating gains losses
-12,285.01%-263.32K
-35,770.39%-1.64M
12,163.50%1.73M
-11.96%-3.66M
-312.04%-3.64M
100.27%2.16K
99.67%-4.58K
92.42%-14.36K
-25.17%-3.26M
90.55%-882.99K
Depreciation and amortization
57.58%25.95K
3.21%33.05K
-51.93%32.13K
140.25%139.69K
7.99%24.36K
-25.34%16.47K
228.21%32.02K
1,670.31%66.85K
307.58%58.15K
469.33%22.56K
Remuneration paid in stock
-27.43%15.86K
43.10%44.03K
34.35%53.13K
-75.21%120.98K
-57.43%28.82K
13.40%21.85K
-90.76%30.77K
-41.90%39.55K
23.09%487.94K
-42.44%67.68K
Other non cashItems
--0
--0
--224.49K
----
----
----
----
----
----
----
Change In working capital
-74.49%56.67K
790.17%659.18K
56.14%-326.87K
-169.94%-1.03M
-70.44%-412.21K
-77.35%222.17K
-122.89%-95.51K
-334.66%-745.19K
236.03%1.47M
68.58%-241.84K
-Change in receivables
125.63%9.7K
34.44%8.08K
-34.20%29.83K
151.20%21.04K
140.47%7.53K
-129.02%-37.83K
108.73%6.01K
153.96%45.33K
-39.87%-41.1K
36.67%-18.61K
-Change in prepaid assets
16.90%110.75K
448.89%431.74K
-442.78%-402.07K
-77.09%142.65K
52.92%-148.04K
-53.00%94.74K
-83.12%78.66K
-56.49%117.3K
178.34%622.6K
56.87%-314.46K
-Change in payables and accrued expense
-167.70%-111.88K
161.53%110.85K
105.00%45.37K
-233.87%-1.19M
-397.83%-271.7K
-74.53%165.25K
-988.26%-180.18K
-787.81%-907.82K
444.07%892.27K
908.34%91.23K
-Change in other working capital
--48.1K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
29.78%-751.85K
57.41%-736.54K
47.54%-1.3M
26.56%-6.58M
64.08%-1.3M
-10.66%-1.07M
7.95%-1.73M
0.74%-2.49M
-86.70%-8.96M
-14.81%-3.61M
Investing cash flow
Cash flow from continuing investing activities
-217.59%-23.18K
4.76%-9.08K
86.71%-2.62K
-1.45%-46.36K
41.75%-9.8K
-56.50%-7.3K
55.81%-9.54K
-647.39%-19.73K
-43.68%-45.7K
-20.58%-16.82K
Net PPE purchase and sale
--0
--0
--0
78.11%-4.31K
99.98%-1
--0
88.89%-1.64K
---2.67K
---19.7K
---5.42K
Net intangibles purchas and sale
-217.59%-23.18K
-14.97%-9.08K
84.62%-2.62K
-61.71%-42.05K
14.02%-9.79K
-42.50%-7.3K
-15.31%-7.9K
-546.14%-17.06K
18.24%-26.01K
18.32%-11.39K
Cash from discontinued investing activities
Investing cash flow
-217.59%-23.18K
4.76%-9.08K
86.71%-2.62K
-1.45%-46.36K
41.75%-9.8K
-56.50%-7.3K
55.81%-9.54K
-647.39%-19.73K
-43.68%-45.7K
-20.58%-16.82K
Financing cash flow
Cash flow from continuing financing activities
-33.38%-22.24K
12.66%-8.86K
7,851.59%1.7M
-107.67%-361.04K
-106.03%-312.25K
96.38%-16.67K
-63.72%-10.14K
-21.98K
-75.69%4.71M
-62.80%5.18M
Net issuance payments of debt
-33.38%-22.24K
45.83%-8.86K
0.73%-15.95K
-223.81%-66.09K
-755.66%-17K
-36.34%-16.67K
-163.98%-16.35K
---16.06K
---20.41K
---1.99K
Net common stock issuance
--0
--0
--2M
--0
--0
--0
--0
--0
-72.34%5M
----
Proceeds from stock option exercised by employees
--0
--0
5,497.97%16.57K
362.50%296
--0
--0
--0
--296
-100.00%64
-99.99%64
Net other financing activities
--0
--0
-4,692.38%-297.61K
-9.53%-295.25K
----
----
----
---6.21K
61.41%-269.56K
248.81%179K
Cash from discontinued financing activities
Financing cash flow
-33.38%-22.24K
12.66%-8.86K
7,851.59%1.7M
-107.67%-361.04K
-106.03%-312.25K
96.38%-16.67K
-63.72%-10.14K
---21.98K
-75.69%4.71M
-62.80%5.18M
Net cash flow
Beginning cash position
-50.06%3.08M
-51.50%3.84M
-66.96%3.45M
-29.83%10.43M
-42.86%5.07M
-40.81%6.16M
-36.28%7.91M
-29.83%10.43M
10,954.34%14.87M
126.44%8.87M
Current changes in cash
27.17%-797.27K
56.86%-754.48K
115.71%397.09K
-62.59%-6.99M
-204.79%-1.62M
23.61%-1.09M
8.26%-1.75M
-0.82%-2.53M
-129.57%-4.3M
-85.63%1.55M
Effect of exchange rate changes
8,045.12%19.55K
-154.37%-2.49K
-903.19%-9.32K
102.97%4.04K
-109.02%-1.45K
99.78%-246
105.02%4.58K
-97.60%1.16K
-169.51%-136.15K
-91.78%16.1K
End cash Position
-54.61%2.3M
-50.06%3.08M
-51.50%3.84M
-66.96%3.45M
-66.96%3.45M
-42.86%5.07M
-40.81%6.16M
-36.28%7.91M
-29.83%10.43M
-29.83%10.43M
Free cash from
28.11%-775.03K
57.12%-745.62K
47.84%-1.31M
26.41%-6.63M
63.98%-1.31M
-10.88%-1.08M
8.49%-1.74M
0.06%-2.5M
-86.42%-9.01M
-14.83%-3.63M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 29.78%-751.85K57.41%-736.54K47.54%-1.3M26.56%-6.58M64.08%-1.3M-10.66%-1.07M7.95%-1.73M0.74%-2.49M-86.70%-8.96M-14.81%-3.61M
Net income from continuing operations 55.98%-587.01K110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M
Operating gains losses -12,285.01%-263.32K-35,770.39%-1.64M12,163.50%1.73M-11.96%-3.66M-312.04%-3.64M100.27%2.16K99.67%-4.58K92.42%-14.36K-25.17%-3.26M90.55%-882.99K
Depreciation and amortization 57.58%25.95K3.21%33.05K-51.93%32.13K140.25%139.69K7.99%24.36K-25.34%16.47K228.21%32.02K1,670.31%66.85K307.58%58.15K469.33%22.56K
Remuneration paid in stock -27.43%15.86K43.10%44.03K34.35%53.13K-75.21%120.98K-57.43%28.82K13.40%21.85K-90.76%30.77K-41.90%39.55K23.09%487.94K-42.44%67.68K
Other non cashItems --0--0--224.49K----------------------------
Change In working capital -74.49%56.67K790.17%659.18K56.14%-326.87K-169.94%-1.03M-70.44%-412.21K-77.35%222.17K-122.89%-95.51K-334.66%-745.19K236.03%1.47M68.58%-241.84K
-Change in receivables 125.63%9.7K34.44%8.08K-34.20%29.83K151.20%21.04K140.47%7.53K-129.02%-37.83K108.73%6.01K153.96%45.33K-39.87%-41.1K36.67%-18.61K
-Change in prepaid assets 16.90%110.75K448.89%431.74K-442.78%-402.07K-77.09%142.65K52.92%-148.04K-53.00%94.74K-83.12%78.66K-56.49%117.3K178.34%622.6K56.87%-314.46K
-Change in payables and accrued expense -167.70%-111.88K161.53%110.85K105.00%45.37K-233.87%-1.19M-397.83%-271.7K-74.53%165.25K-988.26%-180.18K-787.81%-907.82K444.07%892.27K908.34%91.23K
-Change in other working capital --48.1K------------------------------------
Cash from discontinued investing activities
Operating cash flow 29.78%-751.85K57.41%-736.54K47.54%-1.3M26.56%-6.58M64.08%-1.3M-10.66%-1.07M7.95%-1.73M0.74%-2.49M-86.70%-8.96M-14.81%-3.61M
Investing cash flow
Cash flow from continuing investing activities -217.59%-23.18K4.76%-9.08K86.71%-2.62K-1.45%-46.36K41.75%-9.8K-56.50%-7.3K55.81%-9.54K-647.39%-19.73K-43.68%-45.7K-20.58%-16.82K
Net PPE purchase and sale --0--0--078.11%-4.31K99.98%-1--088.89%-1.64K---2.67K---19.7K---5.42K
Net intangibles purchas and sale -217.59%-23.18K-14.97%-9.08K84.62%-2.62K-61.71%-42.05K14.02%-9.79K-42.50%-7.3K-15.31%-7.9K-546.14%-17.06K18.24%-26.01K18.32%-11.39K
Cash from discontinued investing activities
Investing cash flow -217.59%-23.18K4.76%-9.08K86.71%-2.62K-1.45%-46.36K41.75%-9.8K-56.50%-7.3K55.81%-9.54K-647.39%-19.73K-43.68%-45.7K-20.58%-16.82K
Financing cash flow
Cash flow from continuing financing activities -33.38%-22.24K12.66%-8.86K7,851.59%1.7M-107.67%-361.04K-106.03%-312.25K96.38%-16.67K-63.72%-10.14K-21.98K-75.69%4.71M-62.80%5.18M
Net issuance payments of debt -33.38%-22.24K45.83%-8.86K0.73%-15.95K-223.81%-66.09K-755.66%-17K-36.34%-16.67K-163.98%-16.35K---16.06K---20.41K---1.99K
Net common stock issuance --0--0--2M--0--0--0--0--0-72.34%5M----
Proceeds from stock option exercised by employees --0--05,497.97%16.57K362.50%296--0--0--0--296-100.00%64-99.99%64
Net other financing activities --0--0-4,692.38%-297.61K-9.53%-295.25K---------------6.21K61.41%-269.56K248.81%179K
Cash from discontinued financing activities
Financing cash flow -33.38%-22.24K12.66%-8.86K7,851.59%1.7M-107.67%-361.04K-106.03%-312.25K96.38%-16.67K-63.72%-10.14K---21.98K-75.69%4.71M-62.80%5.18M
Net cash flow
Beginning cash position -50.06%3.08M-51.50%3.84M-66.96%3.45M-29.83%10.43M-42.86%5.07M-40.81%6.16M-36.28%7.91M-29.83%10.43M10,954.34%14.87M126.44%8.87M
Current changes in cash 27.17%-797.27K56.86%-754.48K115.71%397.09K-62.59%-6.99M-204.79%-1.62M23.61%-1.09M8.26%-1.75M-0.82%-2.53M-129.57%-4.3M-85.63%1.55M
Effect of exchange rate changes 8,045.12%19.55K-154.37%-2.49K-903.19%-9.32K102.97%4.04K-109.02%-1.45K99.78%-246105.02%4.58K-97.60%1.16K-169.51%-136.15K-91.78%16.1K
End cash Position -54.61%2.3M-50.06%3.08M-51.50%3.84M-66.96%3.45M-66.96%3.45M-42.86%5.07M-40.81%6.16M-36.28%7.91M-29.83%10.43M-29.83%10.43M
Free cash from 28.11%-775.03K57.12%-745.62K47.84%-1.31M26.41%-6.63M63.98%-1.31M-10.88%-1.08M8.49%-1.74M0.06%-2.5M-86.42%-9.01M-14.83%-3.63M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data